Cargando…

Non-invasive diagnostic tool for Parkinson’s disease by sebum RNA profile with machine learning

Parkinson's disease (PD) is a progressive neurodegenerative disease presenting with motor and non-motor symptoms, including skin disorders (seborrheic dermatitis, bullous pemphigoid, and rosacea), skin pathological changes (decreased nerve endings and alpha-synuclein deposition), and metabolic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uehara, Yuya, Ueno, Shin-Ichi, Amano-Takeshige, Haruka, Suzuki, Shuji, Imamichi, Yoko, Fujimaki, Motoki, Ota, Noriyasu, Murase, Takatoshi, Inoue, Takayoshi, Saiki, Shinji, Hattori, Nobutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452747/ https://www.ncbi.nlm.nih.gov/pubmed/34545158 http://dx.doi.org/10.1038/s41598-021-98423-9

Ejemplares similares

Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease
por: Ueno, Shin-Ichi, et al.
Publicado: (2018)

Shared Metabolic Profile of Caffeine in Parkinsonian Disorders
por: Takeshige‐Amano, Haruka, et al.
Publicado: (2020)

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy
por: Mori, Akio, et al.
Publicado: (2019)

Nonmercaptalbumin as an oxidative stress marker in Parkinson’s and PARK2 disease
por: Ueno, Shin‐Ichi, et al.
Publicado: (2020)

Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease
por: Fujimaki, Motoki, et al.
Publicado: (2018)

Systemic Metabolic Alteration Dependent on the Thyroid‐Liver Axis in Early PD
por: Miyamoto, Kengo, et al.
Publicado: (2022)

A metabolic profile of polyamines in parkinson disease: A promising biomarker
por: Saiki, Shinji, et al.
Publicado: (2019)

Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease
por: Saiki, Shinji, et al.
Publicado: (2017)

Diffusion MRI Captures White Matter Microstructure Alterations in PRKN Disease
por: Koinuma, Takahiro, et al.
Publicado: (2021)

Non-invasive human skin transcriptome analysis using mRNA in skin surface lipids
por: Inoue, Takayoshi, et al.
Publicado: (2022)

Identification of Licopyranocoumarin and Glycyrurol from Herbal Medicines as Neuroprotective Compounds for Parkinson's Disease
por: Fujimaki, Takahiro, et al.
Publicado: (2014)

p150(glued)-Associated Disorders Are Caused by Activation of Intrinsic Apoptotic Pathway
por: Ishikawa, Kei-Ichi, et al.
Publicado: (2014)

Metabolomics‐based identification of metabolic alterations in PARK2
por: Okuzumi, Ayami, et al.
Publicado: (2019)

An optimal method for quantifying the facial sebum level and characterizing facial sebum features
por: Liu, Yujie, et al.
Publicado: (2023)

Discovery of Volatile Biomarkers of Parkinson’s Disease from Sebum
por: Trivedi, Drupad K., et al.
Publicado: (2019)

Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease
por: Sinclair, Eleanor, et al.
Publicado: (2021)

Acute psychosis as an initial manifestation of hypothyroidism: a case report
por: Ueno, Shinichi, et al.
Publicado: (2015)

Sebaceous-immunobiology is orchestrated by sebum lipids
por: Lovászi, Marianna, et al.
Publicado: (2017)

The Difference in Sebum Secretion Affecting Development of Acne
por: Jung, In Soon, et al.
Publicado: (2019)

Sweat and Sebum Preferences of the Human Skin Microbiota
por: Swaney, Mary Hannah, et al.
Publicado: (2023)

Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson’s disease: a pilot study
por: Yoritaka, Asako, et al.
Publicado: (2021)

Multi-year whole-blood transcriptome data for the study of onset and progression of Parkinson’s Disease
por: Valentine, Matthew N. Z., et al.
Publicado: (2019)

Analytical and clinical validity of wearable, multi-sensor technology for assessment of motor function in patients with Parkinson’s disease in Japan
por: Oyama, Genko, et al.
Publicado: (2023)

Reversible Pisa syndrome caused by chronic subdural hematoma in a patient with Parkinson’s disease: a case report
por: Igami, Eriko, et al.
Publicado: (2022)

Scalp Microbiome and Sebum Composition in Japanese Male Individuals with and without Androgenetic Alopecia
por: Suzuki, Kazuhiro, et al.
Publicado: (2021)

Marked Reduction in the Striatal Dopamine Transporter Uptake During the Early Stage of Motor Symptoms in Patients with the MAPT N279K Mutation
por: Takeshige, Haruka, et al.
Publicado: (2018)

Brain White-Matter Degeneration Due to Aging and Parkinson Disease as Revealed by Double Diffusion Encoding
por: Kamiya, Kouhei, et al.
Publicado: (2020)

Application of Sebum Lipidomics to Biomarkers Discovery in Neurodegenerative Diseases
por: Briganti, Stefania, et al.
Publicado: (2021)

Parkinson’s disease: deep learning with a parameter-weighted structural connectome matrix for diagnosis and neural circuit disorder investigation
por: Yasaka, Koichiro, et al.
Publicado: (2021)

Propagative α-synuclein seeds as serum biomarkers for synucleinopathies
por: Okuzumi, Ayami, et al.
Publicado: (2023)

White matter microstructures in Parkinson's disease with and without impulse control behaviors
por: Takeshige‐Amano, Haruka, et al.
Publicado: (2022)

Neurocognitive and psychiatric disorders‐related axonal degeneration in Parkinson's disease
por: Andica, Christina, et al.
Publicado: (2020)

Metabolomic analysis data of MPP(+)-exposed SH-SY5Y cells using CE-TOFMS
por: Amo, Taku, et al.
Publicado: (2020)

Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review
por: Tsunemi, Taiji, et al.
Publicado: (2021)

Sebum/Meibum Surface Film Interactions and Phase Transitional Differences
por: Mudgil, Poonam, et al.
Publicado: (2016)

The assessment of skin sebum and moisture content of infants with atopic dermatitis
por: GÜNEŞ, Hatice, et al.
Publicado: (2020)

No skin off your back: the sampling and extraction of sebum for metabolomics
por: Géhin, C., et al.
Publicado: (2023)

Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson’s disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group study (CONST-PD)
por: Hatano, Taku, et al.
Publicado: (2022)

Influence of azelaic and mandelic acid peels on sebum secretion in ageing women
por: Wójcik, Aneta, et al.
Publicado: (2013)

An integrated analysis and comparison of serum, saliva and sebum for COVID-19 metabolomics
por: Spick, Matt, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1f25se23l5qqvcq57sp82kqg9p